Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

The use of anthracycline chemotherapy is limited by the occurrence of cardiotoxicity. In an effort to prevent this cardiotoxicity, different anthracycline dosage schedules (i.e. peak doses and infusion durations) have been studied.